research
A research team led by Professor Kwang-Wook Choi and Dr. Seong-Tae Hong from the Department of Biological Sciences at KAIST has successfully investigated the operational mechanism of the protein Ataxia Telangiectasia Mutated (ATM), an essential protein to the function of a crucial key enzyme that repairs the damaged DNA which stores biometric information. The results were published on December 19th Nature Communications online edition.
All organisms, including humans, constantly strive to protect the information within their DNA from damages posed by a number of factors, such as carbonized materials in our daily food intake, radioactive materials such as radon emitting from the cement of buildings or ultraviolet of the sunlight, which could be a trigger for cancer.
In order to keep the DNA information safe, the organisms are always carrying out complex and sophisticated DNA repair work, which involves the crucial DNA damage repair protein ATM. Consequently, a faulty ATM leads to higher risks of cancer.
Until now, academia predicted that the Translationally Controlled Tumor Protein (TCTP) will play an important role in regulating the function of ATM. However, since most of main research regarding TCTP has only been conducted in cultured cells, it was unable to identify exactly what mechanisms TCTP employs to control ATM.
The KAIST research team identified that TCTP can combine with ATM or increase the enzymatic activity of ATM. In addition, Drosophilia, one of the most widely used model organisms for molecular genetics, has been used to identify that TCTP and ATM play a very important role in repairing the DNA damaged by radiation. This information has allowed the researchers to establish TCTP’s essential function in maintaining the DNA information in cell cultures and even in higher organisms, and to provide specific and important clues to the regulation of ATM by TCTP.
Professor Kwang-Wook Choi said, “Our research is a good example that basic research using Drosophilia can make important contributions to understanding the process of diseases, such as cancer, and to developing adequate treatment.”
The research has been funded by the Ministry of Science, ICT and Future Planning, Republic of Korea, and the National Research Foundation of Korea.
Figure 1. When the amount of TCTP protein is reduced, cells of the Drosophila's eye are abnormally deformed by radiation. Scale bars = 200mm
-
research KAIST Develops Wearable Ultrasound Sensor Enabling Noninvasive Treatment Without Surgery
<(From Left) Professor Hyunjoo Jenny Lee, Dr.Sang-Mok Lee, Ph.D candidate Xiaojia Liang> Conventional wearable ultrasound sensors have been limited by low power output and poor structural stability, making them unsuitable for high-resolution imaging or therapeutic applications. A KAIST research team has now overcome these challenges by developing a flexible ultrasound sensor with statically adjustable curvature. This breakthrough opens new possibilities for wearable medical devices that
2025-11-12 -
research KAIST Exports Global License for New Drug Candidate for Intractable Epilepsy Worth 750 Billion KRW
<(From Left) Professor Jeong Ho Lee, CEO Cheolwon Park, Principal Researcher Sang-min Park> KAIST (President Kwang Hyung Lee) announced on the 9th of October that Sovargen (co-led by CEOs Cheolwon Park and Jeong Ho Lee), a faculty startup led by Professor Jeong Ho Lee of the KAIST Graduate School of Medical Science and Engineering, has successfully achieved a global technology export deal worth a total of 750 billion KRW. The deal involves an innovative RNA-based new drug candidate for
2025-10-10 -
research 3D Printing Becomes Stronger and More Economical with Light and AI
<(Front) Ph.D. candidate Jisoo Nam, (Back row, from left) Ph.D. candidate Boxin Chen, Professor Miso Kim> Photocurable 3D printing, widely used for everything from dental treatments to complex prototype manufacturing, is fast and precise but has the limitation of being fragile and easily broken by impact. A KAIST research team has developed a new technology to overcome this weakness, paving the way for the more robust and economical production of everything from medical implants to prec
2025-09-30 -
research A Breakthrough in Parkinson's Research: Precision Diagnosis and Treatment with AI and Optogenetics
<Research team photo (from top left) Dr. Bobae Hyeon, Professor Daesoo Kim, Director Chang-joon Lee, (right) Professor Won Do Heo> Globally recognized figures like Muhammad Ali and Michael J. Fox have long suffered from Parkinson's disease. The disease presents a complex set of motor symptoms, including tremors, rigidity, bradykinesia, and postural instability. However, traditional diagnostic methods have struggled to sensitively detect changes in the early stages, and drugs targeting
2025-09-22 -
research Opening the Door to Personalized Bipolar Disorder Treatment
<(From Left) Professor Jinju Han, Dr. Gyu Hyeon Baek, Dr. Dayeon Kim, Dr. Geurim Son, Dr. Hyunsu Do> Bipolar disorder, also known as 'manic-depressive illness,' a brain disorder known to have afflicted the famous painter Vincent van Gogh, is characterized by recurrent episodes of mania and depression. This disease affects about 1-2% of the world's population, and the risk of suicide is 10 to 30 times higher than in the general population. However, because each patient's response to li
2025-09-10